The current target for our fundraising is the research being done by Dr. Benoît Hédan at the University of Rennes in France. His work with Dr. Catherine André helped to create the histiocytic sarcoma risk test offered by Antagene, a tool to allow breeders to work toward reducing the incidence of histio. It is a step in the right direction, but more research is needed. At this time Dr. Hédan is working on a method to identify histiocytic sarcoma using a blood sample. Their research has identified a genetic mutation that is present in the blood that can be used to diagnose histio months before any clinical signs appear. It detects about half of the histiocytic sarcomas, and his new research is working to identify other mutations that can improve early diagnosis. While we don’t yet have a proven treatment for histio, that will come.